SAMANTHA LEWIS: Open Payments
NPI 1013429513 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 36 payments from 14 companies in 2025. Trend: 2023 $333 · 2024 $463 · 2025 $830
Food & beverage: $765Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $175 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Lilly USA, LLC | 6 | $130 |
| Janssen Biotech, Inc. | 2 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| UCB, Inc. | 2 | $51 |
| Galderma Laboratories, L.P. | 2 | $45 |
| GENZYME CORPORATION | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
Products named: TALTZ, SKYRIZI, COSENTYX, DUPIXENT, TREMFYA, Bimzelx, RINVOQ, NEMLUVIO.
Industry payments across NE — which companies pay providers there.
